These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 38912406)

  • 21. Hyponatremia in Coronavirus Disease-19 Patients: A Retrospective Analysis.
    Machiraju PK; Alex NM; Safinaaz ; Vadamalai V
    Can J Kidney Health Dis; 2021; 8():20543581211067069. PubMed ID: 35003754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.
    Garrido M; Pereira Guedes T; Alves Silva J; Falcão D; Novo I; Archer S; Rocha M; Maia L; Sarmento-Castro R; Pedroto I
    GE Port J Gastroenterol; 2021 Jan; 158(4):1-12. PubMed ID: 34192127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients.
    Izhari MA
    Infect Drug Resist; 2024; 17():1653-1667. PubMed ID: 38707987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated Liver Enzymes along with Comorbidity Is a High Risk Factor for COVID-19 Mortality: A South Indian Study on 1,512 Patients.
    Krishnasamy N; Rajendran K; Barua P; Ramachandran A; Panneerselvam P; Rajaram M
    J Clin Transl Hepatol; 2022 Feb; 10(1):120-127. PubMed ID: 35233380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
    Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
    World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Hospitalized COVID-19 Patients in Terms of Disease Course According to the Presence of Gastrointestinal Symptoms Before and After Admission.
    Kurt EA; Bakkaloğlu OK; Eşkazan T; Akdoğan S; Önal U; Candan S; Karaali R; Mete B; Dikmen Y; Tuncer M; Hatemi İ; Bal K
    Turk J Gastroenterol; 2023 Apr; 34(4):322-331. PubMed ID: 36789985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal manifestations of COVID-19: results from a European centre.
    Leal T; Costa E; Arroja B; Gonçalves R; Alves J
    Eur J Gastroenterol Hepatol; 2021 May; 33(5):691-694. PubMed ID: 33787540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of olfactory dysfunction with lung involvement and severity of COVID-19.
    Yağmur AR; Akbal Çufalı Ş; Aypak A; Köksal M; Güneş YC; Özcan KM
    Ir J Med Sci; 2022 Aug; 191(4):1843-1848. PubMed ID: 34374938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.
    Turgutalp K; Ozturk S; Arici M; Eren N; Gorgulu N; Islam M; Uzun S; Sakaci T; Aydin Z; Sengul E; Demirelli B; Ayar Y; Altiparmak MR; Sipahi S; Mentes IB; Ozler TE; Oguz EG; Huddam B; Hur E; Kazancioglu R; Gungor O; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Odabas AR; Ates K
    BMC Nephrol; 2021 Jan; 22(1):29. PubMed ID: 33446135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Characteristics Predicting Mortality Risk in Hospitalized Geriatric Patients with COVID-19 Pneumonia: a Retrospective Study.
    Gulec-Balbay E; Altundal MMB; Kaypak MK; Cangur S; Kaya S
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India.
    Murugesan M; Govindarajan R; Prakash L; Murugan CK; Jasmine JJ; Krishnasamy N
    Euroasian J Hepatogastroenterol; 2022; 12(1):24-30. PubMed ID: 35990860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sources and clinical significance of aspartate aminotransferase increases in COVID-19.
    Aloisio E; Colombo G; Arrigo C; Dolci A; Panteghini M
    Clin Chim Acta; 2021 Nov; 522():88-95. PubMed ID: 34411557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological and clinical features of 201 COVID-19 patients in Changsha city, Hunan, China.
    Zhou J; Sun J; Cao Z; Wang W; Huang K; Zheng F; Xie Y; Jiang D; Zhou Z
    Medicine (Baltimore); 2020 Aug; 99(34):e21824. PubMed ID: 32846825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digestive manifestations of Covid-19 in children: a retrospective study.
    Jallouli A; Fakiri KE; Nassih H; Qadiry RE; Bourrahouat A; Sab IA; Rada N; Draiss G; Bouskraoui M
    Afr Health Sci; 2023 Sep; 23(3):181-185. PubMed ID: 38357158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19.
    Higuera-de la Tijera F; Servín-Caamaño A; Reyes-Herrera D; Flores-López A; Robiou-Vivero EJA; Martínez-Rivera F; Galindo-Hernández V; Chapa-Azuela O; Chávez-Morales A; Rosales-Salyano VH
    Liver Res; 2021 Mar; 5(1):21-27. PubMed ID: 33520337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.